title: The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.
abstract: Uropathogenic Escherichia coli (UPEC) is responsible for the majority of uncomplicated urinary tract infections (UTI) and represents the most common bacterial infection in adults. UPEC utilizes a wide range of virulence factors to colonize the host, including the novel repeat-in-toxin (RTX) protein TosA, which is specifically expressed in the host urinary tract and contributes significantly to the virulence and survival of UPEC. tosA, found in strains within the B2 phylogenetic subgroup of E. coli, serves as a marker for strains that also contain a large number of well-characterized UPEC virulence factors. The presence of tosA in an E. coli isolate predicts successful colonization of the murine model of ascending UTI, regardless of the source of the isolate. Here, a detailed analysis of the function of tosA revealed that this gene is transcriptionally linked to genes encoding a conserved type 1 secretion system similar to other RTX family members. TosA localized to the cell surface and was found to mediate (i) adherence to host cells derived from the upper urinary tract and (ii) survival in disseminated infections and (iii) to enhance lethality during sepsis (as assessed in two different animal models of infection). An experimental vaccine, using purified TosA, protected vaccinated animals against urosepsis. From this work, it was concluded that TosA belongs to a novel group of RTX proteins that mediate adherence and host damage during UTI and urosepsis and could be a novel target for the development of therapeutics to treat ascending UTIs.
authors.affiliation: Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
authors.forename: Patrick D
authors.initials: PD
authors.lastname: Vigil
authors.forename: Travis J
authors.initials: TJ
authors.lastname: Wiles
authors.forename: Michael D
authors.initials: MD
authors.lastname: Engstrom
authors.forename: Lev
authors.initials: L
authors.lastname: Prasov
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Mulvey
authors.forename: Harry L T
authors.initials: HL
authors.lastname: Mobley
mesh_terms: D000818:Animals; D016470:Bacteremia / Q000382:microbiology*; D001422:Bacterial Adhesion / Q000502:physiology*; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism*; D001428:Bacterial Vaccines; D002460:Cell Line; D004847:Epithelial Cells / Q000382:microbiology; D004927:Escherichia coli Infections / Q000382:microbiology*; D029968:Escherichia coli Proteins / Q000235:genetics / Q000378:metabolism*; D015964:Gene Expression Regulation, Bacterial / Q000502:physiology; D006801:Humans; D051379:Mice; D021381:Protein Transport / Q000502:physiology; D011704:Pyelonephritis / Q000382:microbiology; D018805:Sepsis / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology; D056689:Uropathogenic Escherichia coli / Q000378:metabolism* / Q000472:pathogenicity; D019459:Urothelium / Q000382:microbiology; D014774:Virulence; D015027:Zebrafish
chemical_list: D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D029968:Escherichia coli Proteins; C561978:tosA protein, E coli
references.citation: Trends Microbiol. 1999 Jun;7(6):253-60
references.pmid: 10366863
references.citation: Infect Immun. 2011 Jun;79(6):2335-44
references.pmid: 21422188
references.citation: PLoS Pathog. 2010 Nov 11;6(11):e1001187
references.pmid: 21085611
references.citation: Scand J Infect Dis. 1993;25(6):705-12
references.pmid: 7914381
references.citation: J Clin Microbiol. 2005 May;43(5):2425-34
references.pmid: 15872276
references.citation: J Infect. 2010 Apr;60(4):278-85
references.pmid: 20114061
references.citation: J Med Microbiol. 1980 Feb;13(1):57-68
references.pmid: 6102156
references.citation: Infect Immun. 2008 Jul;76(7):2978-90
references.pmid: 18443089
references.citation: Oral Microbiol Immunol. 1987 Sep;2(3):97-104
references.pmid: 3507626
references.citation: Mol Microbiol. 1991 Mar;5(3):521-8
references.pmid: 2046545
references.citation: FEMS Microbiol Rev. 2010 Nov;34(6):1076-112
references.pmid: 20528947
references.citation: Infect Immun. 1983 Apr;40(1):273-83
references.pmid: 6339403
references.citation: Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):e50-5
references.pmid: 20579748
references.citation: Mol Microbiol. 1994 Mar;11(6):1117-26
references.pmid: 8022281
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4
references.pmid: 12471157
references.citation: EMBO J. 1985 Dec 30;4(13B):3887-93
references.pmid: 2868893
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6504-9
references.pmid: 8692845
references.citation: J Bacteriol. 2009 Jun;191(11):3469-81
references.pmid: 19329634
references.citation: Oral Dis. 1997 Jun;3(2):113-20
references.pmid: 9467352
references.citation: Infect Immun. 1990 May;58(5):1281-9
references.pmid: 2182540
references.citation: Microbiology (Reading). 2001 Feb;147(Pt 2):345-354
references.pmid: 11158351
references.citation: Adv Exp Med Biol. 2000;485:127-31
references.pmid: 11109097
references.citation: Infect Immun. 1983 Oct;42(1):57-63
references.pmid: 6352503
references.citation: mBio. 2010 Nov 23;1(5):
references.pmid: 21116344
references.citation: Mol Microbiol. 2001 Oct;42(2):319-30
references.pmid: 11703657
references.citation: Infect Immun. 2007 Jan;75(1):278-89
references.pmid: 17074858
references.citation: J Med Microbiol. 1993 Sep;39(3):225-32
references.pmid: 8366522
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
references.pmid: 10829079
references.citation: mBio. 2011 May 03;2(3):e00066-11
references.pmid: 21540363
references.citation: FEBS J. 2010 Aug;277(16):3368-81
references.pmid: 20646069
references.citation: Infect Immun. 2007 Nov;75(11):5079-84
references.pmid: 17646359
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12879-84
references.pmid: 16912116
references.citation: J Bacteriol. 2007 May;189(9):3532-46
references.pmid: 17351047
references.citation: Clin Infect Dis. 2005 Sep 15;41(6):848-54
references.pmid: 16107985
references.citation: PLoS Pathog. 2009 Dec;5(12):e1000697
references.pmid: 20019794
references.citation: Rev Infect Dis. 1983 Mar-Apr;5 Suppl 1:S173-80
references.pmid: 6221388
references.citation: Rev Infect Dis. 1990 Nov-Dec;12(6):1008-18
references.pmid: 2267481
references.citation: Mol Genet Genomics. 2002 May;267(3):370-9
references.pmid: 12073039
references.citation: EMBO J. 2000 Apr 3;19(7):1450-7
references.pmid: 10747013
references.citation: Biochim Biophys Acta. 1991 Apr 29;1077(3):316-24
references.pmid: 1827596
references.citation: Infect Immun. 2008 Feb;76(2):771-80
references.pmid: 18039830
references.citation: Mol Microbiol. 1998 Nov;30(3):513-23
references.pmid: 9822817